Evidence map›Paper›PMID 41690955›Full record

ArticleNature communications2026

Structure and mechanism of the HECT ligase HECTD3.

Jessica Huber, Diego Esposito, Sarah Maslen, Dominic O Chambers, J Mark Skehel, Katrin Rittinger

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jessica HuberMolecular Structure of Cell Signalling Laboratory, The Francis Crick Institute, London, UK.
Diego EspositoMolecular Structure of Cell Signalling Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-4042-8856
Sarah MaslenProteomics Science Technology Platform, The Francis Crick Institute, London, UK.
Dominic O ChambersMolecular Structure of Cell Signalling Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0009-0001-3727-4465
J Mark SkehelProteomics Science Technology Platform, The Francis Crick Institute, London, UK.
Katrin RittingerMolecular Structure of Cell Signalling Laboratory, The Francis Crick Institute, London, UK. katrin.rittinger@crick.ac.uk.ORCID http://orcid.org/0000-0002-7698-4435

Funding

Wellcome Trust CC2000Wellcome Trust CC2075Wellcome Trust (Wellcome) 218785/Z/19/Z
6 · The paper itself

Abstract

HECT E3 ligases regulate many cellular processes, yet how they recognise their substrates and synthesise specific types of poly-ubiquitin chains is still incompletely understood. HECTD3, a member of the "other HECT" family, is implicated in the regulation of inflammation, apoptosis, and infection and highly expressed in several cancers. These functions are largely attributed to its ligase activity and modification of diverse substrates with different types of ubiquitin chains. We present a detailed analysis of the ligase activity of HECTD3, including its ubiquitin linkage preferences, oligomeric state and substrate ubiquitination. Using cryo-EM, we provide the full-length structures of HECTD3 in both apo and ubiquitin-loaded forms, revealing key insights into its domain organisation, including discovery of a distinct fold of the N-terminal region, and mechanistic features. Some of these are shared with other HECT ligases, while others are unique to HECTD3 and contribute to differences in its catalytic mechanisms and functional diversity.

Indexed as

Ubiquitin-Protein LigasesCryoelectron MicroscopyHumansModels, MolecularProtein DomainsSubstrate SpecificityUbiquitinUbiquitinationUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID41690955
PMCPMC13018541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.